PHARMACYREPUBLIC_LIMITED - Accounts

Company registration number 06965839 (England and Wales)
PHARMACYREPUBLIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2022
PHARMACYREPUBLIC LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
PHARMACYREPUBLIC LIMITED
BALANCE SHEET
AS AT
31 JULY 2022
31 July 2022
- 1 -
2022
2021
Notes
£
£
£
£
Fixed assets
Tangible assets
3
42,385
41,747
Current assets
Stocks
155,405
148,945
Debtors
4
633,837
789,212
Cash at bank and in hand
552,016
487,719
1,341,258
1,425,876
Creditors: amounts falling due within one year
5
(609,935)
(726,747)
Net current assets
731,323
699,129
Total assets less current liabilities
773,708
740,876
Provisions for liabilities
681
1,540
Net assets
774,389
742,416
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
774,289
742,316
Total equity
774,389
742,416

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 July 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 27 April 2023 and are signed on its behalf by:
Usama Tariq
Director
Company Registration No. 06965839
PHARMACYREPUBLIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2022
- 2 -
1
Accounting policies
Company information

Pharmacyrepublic Limited is a private company limited by shares incorporated in England and Wales. The registered office is 138 Barking Road, London, UK, E6 3BD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% on reducing balance
Motor vehicles
20% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

PHARMACYREPUBLIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2022
1
Accounting policies
(Continued)
- 3 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

 

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

1.7
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

1.8
Hire purchase and leasing commitments

Rentals paid under operating leases were charged to profit or loss on a straight line basis over the period of the lease.

1.9
Government grants

Coronavirus NHS grant was received in previous year and recognised in other operating income.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total
40
36
PHARMACYREPUBLIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2022
- 4 -
3
Tangible fixed assets
Plant and equipment
Motor vehicles
Total
£
£
£
Cost
At 1 August 2021
91,590
32,899
124,489
Additions
11,235
-
0
11,235
At 31 July 2022
102,825
32,899
135,724
Depreciation and impairment
At 1 August 2021
61,316
21,426
82,742
Depreciation charged in the year
8,302
2,295
10,597
At 31 July 2022
69,618
23,721
93,339
Carrying amount
At 31 July 2022
33,207
9,178
42,385
At 31 July 2021
30,274
11,473
41,747
4
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
378,103
588,662
Other debtors
255,734
200,550
633,837
789,212
5
Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
515,408
504,688
Corporation tax
51,287
98,359
Other creditors
43,240
123,700
609,935
726,747
PHARMACYREPUBLIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2022
- 5 -
6
Directors' transactions

The following advances and credits to directors subsisted during the years ended 31 July 2022 and 31 July 2021:

Description
% Rate
Opening balance
Closing balance
£
£
Shazlee Ahsan
-
35,494
35,494
Asif bashir
-
35,121
35,121
Usama Tariq
-
35,121
35,121
105,736
105,736

The loans are unsecured, interest free and repayable on demand.

7
Ultimate Controlling Party

The company is jointly controlled by Asif Bashir, Shazlee Ahsan and Usama Tariq.

2022-07-312021-08-01false27 April 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityShazlee AhsanAsif bashirUsama Tariq069658392021-08-012022-07-31069658392022-07-31069658392021-07-3106965839core:PlantMachinery2022-07-3106965839core:MotorVehicles2022-07-3106965839core:PlantMachinery2021-07-3106965839core:MotorVehicles2021-07-3106965839core:CurrentFinancialInstrumentscore:WithinOneYear2022-07-3106965839core:CurrentFinancialInstrumentscore:WithinOneYear2021-07-3106965839core:CurrentFinancialInstruments2022-07-3106965839core:CurrentFinancialInstruments2021-07-3106965839core:ShareCapital2022-07-3106965839core:ShareCapital2021-07-3106965839core:RetainedEarningsAccumulatedLosses2022-07-3106965839core:RetainedEarningsAccumulatedLosses2021-07-3106965839bus:Director32021-08-012022-07-3106965839core:PlantMachinery2021-08-012022-07-3106965839core:MotorVehicles2021-08-012022-07-31069658392020-08-012021-07-3106965839core:PlantMachinery2021-07-3106965839core:MotorVehicles2021-07-31069658392021-07-3106965839core:WithinOneYear2022-07-3106965839core:WithinOneYear2021-07-3106965839bus:PrivateLimitedCompanyLtd2021-08-012022-07-3106965839bus:SmallCompaniesRegimeForAccounts2021-08-012022-07-3106965839bus:FRS1022021-08-012022-07-3106965839bus:AuditExemptWithAccountantsReport2021-08-012022-07-3106965839bus:Director12021-08-012022-07-3106965839bus:Director22021-08-012022-07-3106965839bus:FullAccounts2021-08-012022-07-31xbrli:purexbrli:sharesiso4217:GBP